PTAB Denies Novartis' Challenge To Cancer Drug Patents
The Patent Trial and Appeal Board has declined to review two Plexxikon Inc. patents related to a skin cancer treatment, dealing a setback to Novartis Pharmaceuticals Corp., which is facing infringement...To view the full article, register now.
Already a subscriber? Click here to view full article